Your browser doesn't support javascript.
loading
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial.
Weisel, Katja C; Scheid, Christof; Zago, Manola; Besemer, Britta; Mai, Elias K; Haenel, Mathias; Duerig, Jan; Munder, Markus; Lindemann, Hans-Walter; Seckinger, Anja; Kunz, Christina; Benner, Axel; Hose, Dirk; Jauch, Anna; Salwender, Hans; Goldschmidt, Hartmut.
Afiliação
  • Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. k.weisel@uke.de.
  • Scheid C; Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany. k.weisel@uke.de.
  • Zago M; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany.
  • Besemer B; Center for Clinical Trials, University Hospital of Tuebingen, Tuebingen, Germany.
  • Mai EK; Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany.
  • Haenel M; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany.
  • Duerig J; Clinic of Internal Medicine III, Hematology and Oncology, Clinic of Chemnitz, Chemnitz, Germany.
  • Munder M; Department of Hematology, University Hospital Essen, Essen, Germany.
  • Lindemann HW; Department of Hematology, Oncology, and Pneumology, University Medical Center Mainz, Mainz, Germany.
  • Seckinger A; Clinic for Haematology/Oncology, Catholic Hospital Hagen, Hagen, Germany.
  • Kunz C; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany.
  • Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Hose D; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Jauch A; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany.
  • Salwender H; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Goldschmidt H; Department of Hematology and Oncology, Asklepios Hospital Hamburg Altona, Hamburg, Germany.
Blood Cancer J ; 9(4): 45, 2019 04 08.
Article em En | MEDLINE | ID: mdl-30962424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Mieloma Múltiplo Limite: Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Mieloma Múltiplo Limite: Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article